Bradley M. Nagel sold $429k of ELMD
Chief Financial Officer at Electromed, Inc.. 11,801 shares at an average of $36.35, traded Jun 4, 2026, filed Jun 8, 2026.
Score components
- +22RoleCFO
- +17Trade size$429k at market
- +10Share of holdings soldSold 38% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-019883, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | MOption exercise Common Stock | +4,334 | $10.25 | $44k | 26,172 | Jun 8, 2026 |
| Jun 4, 2026 | MOption exercise Common Stock | +5,267 | $10.71 | $56k | 31,439 | Jun 8, 2026 |
| Jun 4, 2026 | SOpen-market sale Common Stock | -11,620 | $36.34 | $422k | 19,819 | Jun 8, 2026 |
| Jun 4, 2026 | SOpen-market sale Common Stock | -181 | $37.11 | $6,718 | 19,638 | Jun 8, 2026 |
| Jun 4, 2026 | MOption exercise Employee Stock Option (right to buy)derivative | -4,334 | $0.00 | $0 | 2,166 | Jun 8, 2026 |
| Jun 4, 2026 | MOption exercise Employee Stock Option (right to buy)derivative | -5,267 | $0.00 | $0 | 2,633 | Jun 8, 2026 |
Related signals
Other insiders at Electromed, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | Electromed, Inc. | James L. Cunniff CEO and President | $354k 9,700 shares | -6% | |
| 45Moderate | ELMDsell Electromed, Inc. | Kathleen Skarvan director | $1.4M 40,000 shares | -53% | |
| 60Notable | ELMDsell Electromed, Inc. | Andrew Summers director | $1.6M 65,714 shares | -100% | |
| 58Moderate | Electromed, Inc. | Andrew Summers director | $3.1M 111,475 shares | -37% | |
| 63Notable | Electromed, Inc. | Kathleen Skarvan director | $2.3M 76,583 shares | -95% | |
| 45Moderate | ELMDsell Electromed, Inc. | Andrew Summers director | $1.1M 37,404 shares | -12% | |
| 53Moderate | Electromed, Inc. | Andrew Summers director | $2.0M 65,630 shares | -19% | |
| 78Notable | Electromed, Inc. | Kathleen Skarvan director | $4.2M 150,000 shares | -103% | |
| 46Moderate | ELMDbuy Electromed, Inc. | James L. Cunniff CEO and President | $137k 9,000 shares | +900% | |
| 36Weak | ELMDbuy Electromed, Inc. | Andrew Summers director | $302k 28,797 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.